Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer
Michelle L. Baglia, Yong Cui, Tao Zheng, Gong Yang, Honglan Li, Mingrong You, Liling Xu, Harvey Murff, Yu-Tang Gao, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
Cancer Res Treat. 2019;51(2):538-546.   Published online 2018 Jul 2     DOI: https://doi.org/10.4143/crt.2017.591
Citations to this article as recorded by Crossref logo
Antidiabetic Drugs in Breast Cancer Patients
Wojciech Garczorz, Agnieszka Kosowska, Tomasz Francuz
Cancers.2024; 16(2): 299.     CrossRef
Association of metformin and statin uses with the prognosis of colon cancer: a meta-analysis
Yanyan Xu, Hao Che, Jiang Liu, Pingjiang Ye
European Journal of Cancer Prevention.2024;[Epub]     CrossRef
A Mathematical Model of the Disruption of Glucose Homeostasis in Cancer Patients
Noah Salentine, Jonathan Doria, Chinh Nguyen, Gabriella Pinter, Shizhen Emily Wang, Peter Hinow
Bulletin of Mathematical Biology.2023;[Epub]     CrossRef
Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies
Lingna Li, Jianing Huang, Tongmin Huang, Jie Yao, Yeyuan Zhang, Meiling Chen, Haojie Shentu, Haiying Lou, Flavia Prodam
International Journal of Endocrinology.2023; 2023: 1.     CrossRef
Shared Lifestyle-Related Risk Factors of Cardiovascular Disease and Cancer: Evidence for Joint Prevention
Farzad Masoudkabir, Noushin Mohammadifard, Arya Mani, Andrew Ignaszewski, Margot K. Davis, Golnaz Vaseghi, Marjan Mansourian, Christopher Franco, Carolyn Gotay, Nizal Sarrafzadegan, Francesco Giallauria
The Scientific World Journal.2023; 2023: 1.     CrossRef
Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies
Mansour Bahardoust, Safa Mousavi, Zahra Deylami Moezi, Mohsen Yarali, Ali Tayebi, Faranak Olamaeian, Adnan Tizmaghz
Journal of Gastrointestinal Cancer.2023;[Epub]     CrossRef
Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms
Li Wang, Zhe Zhang, Eusebio Chiefari
Journal of Diabetes Research.2023; 2023: 1.     CrossRef
Perspectives of metformin use in endometrial cancer and other gynaecological malignancies
Bartłomiej Barczyński, Karolina Frąszczak, Jan Kotarski
Journal of Drug Targeting.2022; 30(4): 359.     CrossRef
Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer
L. Fernández-Arce, N. Robles-Rodríguez, A. Fernández-Feito, A. Llaneza-Folgueras, A. I. Encinas-Muñiz, A. Lana
Cancer Causes & Control.2022; 33(2): 271.     CrossRef
Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications
Guan-Hua Yu, Shuo-Feng Li, Ran Wei, Zheng Jiang, Eusebio Chiefari
Journal of Diabetes Research.2022; 2022: 1.     CrossRef
Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model
Nana Wei, Jinmiao Lu, Zhibing Lin, Xiaoyu Wang, Mengmeng Cai, Shengyao Jiang, Xiaoyu Chen, Shilan Zhu, Dong Zhang, Li Cui
Frontiers in Oncology.2022;[Epub]     CrossRef
The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Sami Erkinantti, Ari Hautakoski, Reijo Sund, Martti Arffman, Elina Urpilainen, Ulla Puistola, Esa Läärä, Arja Jukkola, Peeter Karihtala
Biomolecules.2022; 12(9): 1301.     CrossRef
Metformin protects against diabetes-induced heart injury and dunning prostate cancer model
BB Bayrak, P Koroglu, O Karabulut Bulan, R Yanardag
Human & Experimental Toxicology.2021; 40(2): 297.     CrossRef
Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
Alejandro Schcolnik-Cabrera, Alma Chavez-Blanco, Guadalupe Dominguez-Gomez, Mandy Juarez, Ariana Vargas-Castillo, Rafael Isaac Ponce-Toledo, Donna Lai, Sheng Hua, Armando R. Tovar, Nimbe Torres, Delia Perez-Montiel, Jose Diaz-Chavez, Alfonso Duenas-Gonzal
Scientific Reports.2021;[Epub]     CrossRef
Repurposing metformin for the treatment of gastrointestinal cancer
Ademar Dantas Cunha Júnior, Arinilda Campos Bragagnoli, Felipe Osório Costa, José Barreto Campello Carvalheira
World Journal of Gastroenterology.2021; 27(17): 1883.     CrossRef
Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study
Jiaojiao Zheng, Giola Santoni, Shao-Hua Xie, Jesper Lagergren
British Journal of Cancer.2021; 125(2): 277.     CrossRef
The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
Chin-Hsiao Tseng
Biomolecules.2021; 11(7): 1022.     CrossRef
Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study
Byoung Hyuck Kim, Moon-June Cho, Jeanny Kwon
International Journal of Clinical Oncology.2021; 26(11): 2004.     CrossRef
Progress in understanding of relationship between diabetes and colorectal cancer
Guan-Hua Yu, Zheng Jiang
World Chinese Journal of Digestology.2021; 29(23): 1323.     CrossRef
The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
Y. Shuai, C. Li, X. Zhou
Clinical and Translational Oncology.2020; 22(9): 1580.     CrossRef
The right place for metformin today
Guntram Schernthaner, Gerit-Holger Schernthaner
Diabetes Research and Clinical Practice.2020; 159: 107946.     CrossRef
Suppressive effects of metformin on colorectal adenoma incidence and malignant progression
Min Deng, Siqin Lei, Dongdong Huang, Hui Wang, Shuli Xia, Enping Xu, Yihua Wu, Honghe Zhang
Pathology - Research and Practice.2020; 216(2): 152775.     CrossRef

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend

Jing Zhang, Liping Wen, Quan Zhou, Kuifeng He, Lisong Teng
Cancer Management and Research.2020; Volume 12: 8545.     CrossRef
Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer? A Systematic Review and Meta-Analysis
Dong Peng, Yu-Xi Cheng, Wei Zhang
Diabetes Therapy.2020; 11(12): 2863.     CrossRef
Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
Alejandro Schcolnik‑Cabrera, Alma Chavez‑Blanco, Guadalupe Dominguez‑Gomez, Mandy Juarez, Donna Lai, Sheng Hua, Armando Tovar, Jose Diaz‑Chavez, Alfonso Duenas‑Gonzalez
Oncology Letters.2020; 20(3): 3053.     CrossRef
Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
Junichi Kato, Yohei Shirakami, Masahito Shimizu
Gastrointestinal Disorders.2019; 1(2): 273.     CrossRef
Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer
Yong Cui, Wanqing Wen, Tao Zheng, Honglan Li, Yu-Tang Gao, Hui Cai, Mingrong You, Jing Gao, Gong Yang, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
American Journal of Epidemiology.2019; 188(8): 1512.     CrossRef
Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type�2 diabetes mellitus and gastric cancer
Jinhui Liu, Li Yang
Oncology Letters.2019;[Epub]     CrossRef
A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer
Audrius Dulskas, Ausvydas Patasius, Donata Linkeviciute-Ulinskiene, Lina Zabuliene, Giedre Smailyte
Aging.2019; 11(17): 7197.     CrossRef